Liquid Biopsy in Metagone
Cancer treatment can be divided to risk evaluation 、early cancer detection and precision therapy. genomic sequencing play a critical roles in clinical diagnosis 、therapeutics、prognosis and disease monitor.
Association with liquid biopsy, Metagone provides an appropriate method and platform for doctors to set out the suit treatment and drugs.
The global market of liquid biopsy is 410 million dollars in 2015, with the develop of advanced techniques, value of liquid biopsy is expected to $1.94 billion UA dollars in 2020, compound average growth rate of 2015-2020 is 36.2%.